Author

E. Bigelow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

A. Gupta· 1 shared B. J. Christmas· 1 shared C. Rafie· 1 shared D. A. Gaykalova· 1 shared D. N. Sidiropoulos· 1 shared E. F. Davis-Marcisak· 1 shared E. J. Fertig· 1 shared E. M. Jaffee· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Gupta

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Phenotypic shifts of tumor associated macrophages and STAT3 mediated suppression of myeloid derived suppressor cells drive sensitization of HER2+ tumor immunity.

D. N. Sidiropoulos, C. Rafie, B. J. Christmas, E. F. Davis-Marcisak, G. Sharma, E. Bigelow, A. Gupta, S. Yegnasubramanian, V. Stearns, R. M. Connolly, D. A. Gaykalova, L. T. Kagohara, E. M. Jaffee, E. J. Fertig, E. T. Roussos-Torres

The paper uses single-cell RNA-sequencing to show entinostat shifts tumor microenvironment cell states, reducing immunosuppression and enhancing immune checkpoint inhibitor responses in HER2+ breast tumors.

bioRxiv · Jan 29, 2021 · PreprintImmunology